November 23, 2010
Dr. Michael Weitz, patient advocate on LCFA’s Scientific Advisory is featured in this in depth story on KCBS – Los Angeles that aired on November 23, 2010. The story revolves around Dr. Weitz’s battle with lung cancer and the success he is experiencing after testing positive for the ALK mutation and his resulting participation in a clinical trial for Pfizer’s Critzotinib.
KCBS Los Angeles Health Reporter, Lisa Sigell reports.
Click below to watch: